Curis Inc
CRIS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001108205
No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Curis Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 59 | 36 | −23 |
| SharesConverted for a 1-for-20 split | 1.49M | 2.13M | +637.2K (+42.8%) |
| Value | $24.7M | $14.0M | −$10.7M (−43.3%) |
New holders (3)
Institutions that held Curis Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 78,135 | $514.9K | 0.00% |
| Comerica Bank | 100 | $659 | 0.00% |
| Qube Research & Technologies Ltd | 2 | $13 | 0.00% |
Sold out (26)
Institutions that held Curis Inc at the end of Q2 2023 and filed for Q3 2023 without it.